Claret Medical Inc. won FDA clearance for its Sentinel device to capture debris from a transcatheter aortic valve replacement (TAVR) and reduce risk of stroke. Touted by the Santa Rosa, Calif.-based company as the first of its kind in the U.S., the device blocks microphages, fibrin and cholesterol materials loosened during the procedure which can then travel to the brain. Read More
